Application of GSK-3beta as a blood marker in preparation of mental disorder early-diagnosis reagent
A technology for blood markers and mental disorders, applied in the field of early diagnostic reagents for autism spectrum disorders, can solve problems such as unclear expression of related proteins, and achieve the effect of easy discovery
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0021] ASD model mice were constructed according to literature reports (Lieberman, O.J., V. Cartocci, et al. (2020). "mTOR Suppresses Macroautophagy During Striatal Postnatal Development and IsHyperactive in Mouse Models of Autism Spectrum Disorders." Front Cell Neurosci14:70.) . Construction method: Two-month-old C57 / BL6J mice were mated with a male-to-female ratio of 1:1. Female mice were intraperitoneally injected with 600mg / kg VPA on the 12th day of pregnancy.
[0022] 200 μl of blood was collected from newborn mice, and 5 times the volume of lysate (50mM Tris-HCl, pH7.4, 8.5% Sucrose, 10mM β-ME, 2mM EDTA, 50mM NaF, 1mM Na 3 VO 4 And protease inhibitor aprotinin, pepstatin, leupeptin each 10μg / ml, 1.0mM 4-(2-aminoethyl)benzenesulfonyl fluoride hy-drochloride (AEBSF)), ground and cracked in an ice-water bath. After lysis, add an equal volume of 2×Laemmli SDS samplebuffer, and cook in a boiling water bath for 5 minutes. Cooled samples were cooled using Pierce TM 660nm P...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com